SAN DIEGO, Oct. 28 /PRNewswire-FirstCall/ -- Neurocrine Biosciences announces the following Webcast:
If you are unable to participate during the live webcast, the call will be archived at (http://www.videonewswire.com/event.asp?id=52783)
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. The product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com
CONTACT: Claudia Woodworth, IR Manager of Neurocrine Biosciences,
+1-858-617-7759, cwoodworth@neurocrine.com, fax, +1-858-617-7602
Web site: http://www.neurocrine.com/
